No Data
No Data
No Data
No Data
No Data
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
GlobeNewswireApr 22 21:00
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Globe NewswireMar 28 21:00
Avalon GloboCare Extends Exclusive Distribution Agreement for KetoAir Breathalyzer | NASDAQ:ALBT
Proactive InvestorsMar 28 17:29
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
FREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
GlobeNewswireDec 18, 2023 22:00
Avalon GloboCare Partners With Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis
FREEHOLD, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
GlobeNewswireOct 18, 2023 21:00
It's Probably Less Likely That Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Will See A Huge Pay Rise This Year
Key Insights Avalon GloboCare will host its Annual General Meeting on 12th of October Total pay for CEO David Jin includes US$360.0k salary The total compensation is similar to the average for the
Simply Wall StOct 6, 2023 18:21
No Data
No Data